Sculptor Capital LP Immunity Bio, Inc. Call Options Transaction History

Sculptor Capital LP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$3.32 - $6.7 $514,600 - $1.04 Million	-155,000 Reduced 43.66%	200,000 $742,000
Q2 2024 Aug 14, 2024	BUY	$4.82 - $9.15 $506,100 - $960,750	105,000 Added 42.0%	355,000 $2.24 Million
Q1 2024 May 15, 2024	BUY	$3.23 - $6.17 $807,500 - $1.54 Million	250,000 New	250,000 $1.34 Million

204

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.07B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

Stay updated on Sculptor Capital LP with notifications on news.